美股
Lead report
Parabilis Medicines IPO Priced at $19 Per Share, Upsized Offering
Biotech firm Parabilis Medicines completes IPO at $19 per share, upsizing to 12 million shares and raising approximately $228 million, as market focuses on its precision medicine pipeline progress.
